Quick Dispatch:
Your foxo4-dri senolytic or senomorphic Senolytics: charting a new course or enhancing existing anti-tumor therapies? | Cellular Oncology orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your foxo4-dri senolytic or senomorphic Senolytics: charting a new course or enhancing existing anti-tumor therapies? | Cellular Oncology ships.
Need Help?
Questions about foxo4-dri senolytic or senomorphic Senolytics: charting a new course or enhancing existing anti-tumor therapies? | Cellular Oncology, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for foxo4-dri senolytic or senomorphic Senolytics: charting a new course or enhancing existing anti-tumor therapies? | Cellular Oncology in your area.
The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI
26.23
Senolytics against Aging: Snapshot of a Fast-Moving Field
29.87
Heterogeneity of Cellular Senescence, Senotyping, and Targeting by Senolytics and Senomorphics in Lung Diseases
27.85
PDF) Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes
24.85
Peptide Inhibitors Targeting FOXO4-p53 Interactions and Inducing Senescent Cancer Cell-specific Apoptosis
23.37
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
29.38
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytic | DDDT
23.09
